HomeITOS • NASDAQ
add
iTeos Therapeutics Inc
Previous close
$8.55
Day range
$8.41 - $8.73
Year range
$7.54 - $18.75
Market cap
313.09M USD
Avg Volume
613.68K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 48.63M | 13.45% |
Net income | -45.36M | -40.68% |
Net profit margin | — | — |
Earnings per share | -1.05 | -16.67% |
EBITDA | -48.32M | -13.33% |
Effective tax rate | -5.20% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 488.71M | -18.42% |
Total assets | 723.08M | 6.70% |
Total liabilities | 91.38M | 15.12% |
Total equity | 631.69M | — |
Shares outstanding | 36.53M | — |
Price to book | 0.49 | — |
Return on assets | -16.48% | — |
Return on capital | -18.61% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -45.36M | -40.68% |
Cash from operations | -37.35M | -10.21% |
Cash from investing | -91.49M | -503.16% |
Cash from financing | -442.00K | -4,520.00% |
Net change in cash | -127.35M | -954.03% |
Free cash flow | -21.39M | 20.60% |
About
Founded
2011
Headquarters
Website
Employees
157
